SALL2 and lung cancer: Similarly, Silmitasertib transiently increased SALL2 protein levels in SW480 colon cancer cells (Fig. 5F, G, Supplementary Fig. 6A) and H1299 human lung cancer cells (Supplementary Fig. 6B).